Published in Nat Rev Mol Cell Biol on April 20, 2016
Tuning the allosteric regulation of artificial muscarinic and dopaminergic ligand-gated potassium channels by protein engineering of G protein-coupled receptors. Sci Rep (2017) 0.75
Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists. ACS Chem Neurosci (2017) 0.75
How Ligands Illuminate GPCR Molecular Pharmacology. Cell (2017) 0.75
Conformational biosensors reveal allosteric interactions between heterodimeric AT1 angiotensin and prostaglandin F2α receptors. J Biol Chem (2017) 0.75
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
Crystal structure of the β2 adrenergic receptor-Gs protein complex. Nature (2011) 13.92
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol (2003) 9.99
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor. Nature (2011) 9.61
Crystal structure of opsin in its G-protein-interacting conformation. Nature (2008) 8.61
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science (1999) 7.57
Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature (2008) 7.20
High-resolution protein structure determination by serial femtosecond crystallography. Science (2012) 6.90
Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem (1984) 6.58
Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science (1996) 6.50
Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature (1996) 6.32
Structure of an agonist-bound human A2A adenosine receptor. Science (2011) 6.21
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist. Nature (2012) 6.18
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci U S A (2007) 6.04
Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature (2013) 5.75
Structure and function of an irreversible agonist-β(2) adrenoceptor complex. Nature (2011) 5.35
Crystal structure of metarhodopsin II. Nature (2011) 5.05
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. Nature (2011) 4.60
Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science (1996) 4.38
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor. Nature (2011) 4.31
The dynamic process of β(2)-adrenergic receptor activation. Cell (2013) 4.09
Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature (2012) 3.83
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature (2012) 3.83
The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation. Cell (1999) 3.67
Serial femtosecond crystallography of G protein-coupled receptors. Science (2013) 3.58
Projection structure of rhodopsin. Nature (1993) 3.41
Conformational biosensors reveal GPCR signalling from endosomes. Nature (2013) 3.29
Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev (2010) 3.27
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor. Nature (2010) 3.19
Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol (2011) 3.15
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther (2006) 3.15
Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J Biol Chem (2007) 3.07
Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science (2012) 3.07
Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol Sci (2011) 2.89
Biomolecular simulation: a computational microscope for molecular biology. Annu Rev Biophys (2012) 2.85
DEER distance measurements on proteins. Annu Rev Phys Chem (2012) 2.84
Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam. J R Soc Interface (2009) 2.69
Mechanism of the receptor-catalyzed activation of heterotrimeric G proteins. Nat Struct Mol Biol (2006) 2.68
Crystal structure of the adenylyl cyclase activator Gsalpha. Science (1997) 2.68
Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem (2007) 2.59
Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem (1998) 2.45
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature (2015) 2.43
Conformational changes in the G protein Gs induced by the β2 adrenergic receptor. Nature (2011) 2.43
Fine-tuning of GPCR activity by receptor-interacting proteins. Nat Rev Mol Cell Biol (2009) 2.39
Target validation of G-protein coupled receptors. Drug Discov Today (2002) 2.26
Molecular control of δ-opioid receptor signalling. Nature (2014) 2.22
Micro-crystallography comes of age. Curr Opin Struct Biol (2012) 2.17
Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature (2013) 2.14
G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther (2011) 2.13
Arrangement of rhodopsin transmembrane alpha-helices. Nature (1997) 2.10
Location, location, location...site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci (2008) 2.03
Structural flexibility of the G alpha s alpha-helical domain in the beta2-adrenoceptor Gs complex. Proc Natl Acad Sci U S A (2011) 2.03
Differential interaction of spin-labeled arrestin with inactive and active phosphorhodopsin. Proc Natl Acad Sci U S A (2006) 1.94
Inositol-lipid binding motifs: signal integrators through protein-lipid and protein-protein interactions. J Cell Sci (2005) 1.88
Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse. Genomics (2006) 1.80
Morphine side effects in beta-arrestin 2 knockout mice. J Pharmacol Exp Ther (2005) 1.79
Heptahelical receptor signaling: beyond the G protein paradigm. J Cell Biol (1999) 1.78
Structure of β-galactosidase at 3.2-Å resolution obtained by cryo-electron microscopy. Proc Natl Acad Sci U S A (2014) 1.76
Visualization of arrestin recruitment by a G-protein-coupled receptor. Nature (2014) 1.72
Modulation of the arrestin-clathrin interaction in cells. Characterization of beta-arrestin dominant-negative mutants. J Biol Chem (1997) 1.69
Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling. Cell (2015) 1.68
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Nature (2013) 1.68
Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J Biol Chem (2010) 1.66
A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther (2013) 1.62
Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem (2006) 1.54
The selectivity of visual arrestin for light-activated phosphorhodopsin is controlled by multiple nonredundant mechanisms. J Biol Chem (1998) 1.53
Structure of the Angiotensin receptor revealed by serial femtosecond crystallography. Cell (2015) 1.51
The role of ligands on the equilibria between functional states of a G protein-coupled receptor. J Am Chem Soc (2013) 1.48
Mechanism of quenching of phototransduction. Binding competition between arrestin and transducin for phosphorhodopsin. J Biol Chem (1997) 1.46
Automated sample-scanning methods for radiation damage mitigation and diffraction-based centering of macromolecular crystals. J Synchrotron Radiat (2011) 1.44
G-protein-coupled receptor phosphorylation: where, when and by whom. Br J Pharmacol (2008) 1.44
Efficacy of the β₂-adrenergic receptor is determined by conformational equilibrium in the transmembrane region. Nat Commun (2012) 1.40
Monomeric rhodopsin is the minimal functional unit required for arrestin binding. J Mol Biol (2010) 1.33
Structural basis for bifunctional peptide recognition at human δ-opioid receptor. Nat Struct Mol Biol (2015) 1.32
Molecular basis for activation of G protein-coupled receptor kinases. EMBO J (2010) 1.30
How does arrestin assemble MAPKs into a signaling complex? J Biol Chem (2008) 1.30
SIGNAL TRANSDUCTION. Structural basis for nucleotide exchange in heterotrimeric G proteins. Science (2015) 1.29
Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc Natl Acad Sci U S A (2012) 1.27
Energetic analysis of the rhodopsin-G-protein complex links the α5 helix to GDP release. Nat Struct Mol Biol (2013) 1.19
The receptor-bound "empty pocket" state of the heterotrimeric G-protein alpha-subunit is conformationally dynamic. Biochemistry (2006) 1.18
Crystal structure of a common GPCR-binding interface for G protein and arrestin. Nat Commun (2014) 1.16
Propagation of conformational changes during μ-opioid receptor activation. Nature (2015) 1.14
Development of a yeast bioassay to characterize G protein-coupled receptor kinases. Identification of an NH2-terminal region essential for receptor phosphorylation. J Biol Chem (2003) 1.13
WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3. Br J Pharmacol (2014) 1.07
Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs. J Biol Chem (2011) 1.07
Reaction rate and collisional efficiency of the rhodopsin-transducin system in intact retinal rods. Biophys J (1991) 1.06
Rhodopsin-transducin heteropentamer: three-dimensional structure and biochemical characterization. J Struct Biol (2011) 1.05
Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation. Biochemistry (2009) 1.05
Methodological advances: the unsung heroes of the GPCR structural revolution. Nat Rev Mol Cell Biol (2015) 1.03
Dynamics of arrestin-rhodopsin interactions: loop movement is involved in arrestin activation and receptor binding. J Biol Chem (2007) 1.02
Femtosecond crystallography of membrane proteins in the lipidic cubic phase. Philos Trans R Soc Lond B Biol Sci (2014) 1.01
Production of GPCR and GPCR complexes for structure determination. Curr Opin Struct Biol (2013) 0.98
Closely related G-protein-coupled receptors use multiple and distinct domains on G-protein alpha-subunits for selective coupling. J Biol Chem (2003) 0.97
Helix formation in arrestin accompanies recognition of photoactivated rhodopsin. Biochemistry (2009) 0.96
Light causes phosphorylation of nonactivated visual pigments in intact mouse rod photoreceptor cells. J Biol Chem (2005) 0.95
A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus. J Biol Chem (2010) 0.89
Constitutively active rhodopsin mutants causing night blindness are effectively phosphorylated by GRKs but differ in arrestin-1 binding. Cell Signal (2013) 0.87